- Home
- IBEX vs ATXS Comparison
IBEX vs ATXS Comparison
Compare IBEX & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBEX
- ATXS
- Stock Information
- Founded
- IBEX 2017
- ATXS 2008
- Country
- IBEX United States
- ATXS United States
- Employees
- IBEX N/A
- ATXS N/A
- Industry
- IBEX EDP Services
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- IBEX Technology
- ATXS Health Care
- Exchange
- IBEX Nasdaq
- ATXS Nasdaq
- Market Cap
- IBEX 337.3M
- ATXS 401.2M
- IPO Year
- IBEX 2020
- ATXS 2015
- Fundamental
- Price
- IBEX $27.57
- ATXS $5.86
- Analyst Decision
- IBEX Hold
- ATXS Strong Buy
- Analyst Count
- IBEX 2
- ATXS 7
- Target Price
- IBEX $27.00
- ATXS $32.43
- AVG Volume (30 Days)
- IBEX 136.8K
- ATXS 479.1K
- Earning Date
- IBEX 05-08-2025
- ATXS 08-11-2025
- Dividend Yield
- IBEX N/A
- ATXS N/A
- EPS Growth
- IBEX 48.53
- ATXS N/A
- EPS
- IBEX 2.25
- ATXS N/A
- Revenue
- IBEX $535,666,000.00
- ATXS N/A
- Revenue This Year
- IBEX $9.12
- ATXS N/A
- Revenue Next Year
- IBEX $5.80
- ATXS N/A
- P/E Ratio
- IBEX $12.20
- ATXS N/A
- Revenue Growth
- IBEX 5.35
- ATXS N/A
- 52 Week Low
- IBEX $15.15
- ATXS $3.56
- 52 Week High
- IBEX $32.08
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- IBEX 48.65
- ATXS 62.16
- Support Level
- IBEX $27.29
- ATXS $5.43
- Resistance Level
- IBEX $29.00
- ATXS $5.97
- Average True Range (ATR)
- IBEX 0.87
- ATXS 0.44
- MACD
- IBEX -0.28
- ATXS 0.06
- Stochastic Oscillator
- IBEX 30.38
- ATXS 82.37
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.